WASHINGTON The Food and Drug Administration approved a new vaccine to protect people age 11-55 against bacterial meningitis, which is rare but potentially deadly and debilitating.
The French company sanofi pasteur received approval from the federal agen
The Crescent News is available to our paid subscribers.
sign out Welcome,
(edit)